These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 25135692)
21. Can we increase the cure rate of adults with acute lymphoblastic leukemia? Arlin ZA; Feldman EJ Leukemia; 1989 Apr; 3(4):318-20. PubMed ID: 2927182 [No Abstract] [Full Text] [Related]
22. Clinical efficacy of ruxolitinib and chemotherapy in a child with Philadelphia chromosome-like acute lymphoblastic leukemia with Ding YY; Stern JW; Jubelirer TF; Wertheim GB; Lin F; Chang F; Gu Z; Mullighan CG; Li Y; Harvey RC; Chen IM; Willman CL; Hunger SP; Li MM; Tasian SK Haematologica; 2018 Sep; 103(9):e427-e431. PubMed ID: 29773603 [No Abstract] [Full Text] [Related]
23. Philadelphia chromosome-positive acute lymphoblastic leukemia. Lestingi TM; Hooberman AL Hematol Oncol Clin North Am; 1993 Feb; 7(1):161-75. PubMed ID: 8449857 [TBL] [Abstract][Full Text] [Related]
25. Molecular diagnosis and clinical relevance of t(9;22), t(4;11) and t(1 ;19) chromosome abnormalities in a consecutive group of 141 adult patients with acute lymphoblastic leukemia. Rambaldi A; Attuati V; Bassan R; Neonato MG; Viero P; Battista R; Di Bona E; Rossi G; Pogliani E; Ruggeri M; Amaru R; Rivolta A; Giudici G; Biondi A; Barbui T Leuk Lymphoma; 1996 May; 21(5-6):457-66. PubMed ID: 9172811 [TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of ponatinib for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: a case series from a single institute. Kidoguchi K; Ureshino H; Kizuka-Sano H; Yamaguchi K; Katsuya H; Kubota Y; Ando T; Miura M; Takahashi N; Kimura S Int J Hematol; 2021 Aug; 114(2):199-204. PubMed ID: 33907977 [TBL] [Abstract][Full Text] [Related]
28. Allogeneic transplantation for patients with Philadelphia chromosome positive acute lymphoblastic leukemia: Is it imperative in the tyrosine kinase inhibitor era? Litzow MR Best Pract Res Clin Haematol; 2018 Dec; 31(4):357-360. PubMed ID: 30466747 [TBL] [Abstract][Full Text] [Related]
29. Lack of negative impact of Philadelphia chromosome in older patients with acute lymphoblastic leukaemia in the thyrosine kinase inhibitor era: comparison of two prospective parallel protocols. Ribera JM; García O; Fernández-Abellán P; Lavilla E; Bernal MT; González-Campos J; Brunet S; Monteserín MC; Montesinos P; Sarrá J; Calbacho M; Alvarez-Larrán A; Tormo M; Oriol A; Br J Haematol; 2012 Nov; 159(4):485-8. PubMed ID: 22966847 [No Abstract] [Full Text] [Related]
30. Key Markers of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia. Xia M; Zhang H; Lu Z; Gao Y; Liao X; Li H J Pediatr Hematol Oncol; 2016 Aug; 38(6):418-22. PubMed ID: 27438018 [TBL] [Abstract][Full Text] [Related]
31. Philadelphia chromosome-positive mixed phenotype acute leukemia in the imatinib era. Shimizu H; Yokohama A; Hatsumi N; Takada S; Handa H; Sakura T; Nojima Y Eur J Haematol; 2014 Oct; 93(4):297-301. PubMed ID: 24750307 [TBL] [Abstract][Full Text] [Related]
32. Detection of leukemic cells in the CD34(+)CD38(-) bone marrow progenitor population in children with acute lymphoblastic leukemia. George AA; Franklin J; Kerkof K; Shah AJ; Price M; Tsark E; Bockstoce D; Yao D; Hart N; Carcich S; Parkman R; Crooks GM; Weinberg K Blood; 2001 Jun; 97(12):3925-30. PubMed ID: 11389036 [TBL] [Abstract][Full Text] [Related]
34. Outcome of Philadelphia chromosome-positive adult acute lymphoblastic leukemia. Faderl S; Kantarjian HM; Thomas DA; Cortes J; Giles F; Pierce S; Albitar M; Estrov Z Leuk Lymphoma; 2000 Jan; 36(3-4):263-73. PubMed ID: 10674898 [TBL] [Abstract][Full Text] [Related]
35. Dasatinib and low-intensity chemotherapy for Philadelphia chromosome-positive acute lymphoblastic leukemia in a child with Down syndrome. Hirabayashi S; Hasegawa D; Yamamoto K; Nishimura A; Hosoya Y; Shuo T; Kiyokawa N; Miura M; Takahashi N; Manabe A Pediatr Blood Cancer; 2019 May; 66(5):e27612. PubMed ID: 30663211 [No Abstract] [Full Text] [Related]
36. Advanced Philadelphia chromosome positive acute lymphoblastic leukemia patients relapsed after treatment with tyrosine-kinase inhibitors: successful response to clofarabine and cyclophosphamide. Vitale A; Grammatico S; Capria S; Fiocchi C; Foà R; Meloni G Haematologica; 2009 Oct; 94(10):1471-3. PubMed ID: 19608688 [No Abstract] [Full Text] [Related]
37. [Treatment strategy for the patients with Philadelphia chromosome negative acute lymphoblastic leukemia in first remission]. Takeuchi J Rinsho Ketsueki; 2010 Jul; 51(7):460-3. PubMed ID: 20693763 [No Abstract] [Full Text] [Related]
38. CD34+CD38-CD123+ Cells Are Present in Virtually All Acute Myeloid Leukaemia Blasts: A Promising Single Unique Phenotype for Minimal Residual Disease Detection. Al-Mawali A; Pinto AD; Al-Zadjali S Acta Haematol; 2017; 138(3):175-181. PubMed ID: 29065396 [TBL] [Abstract][Full Text] [Related]
39. [Clinical study of 32 patients with adult Philadelphia chromosome-positive acute lymphoblastic leukemia]. Chen XY; Zheng YL; Chen YJ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1567-71. PubMed ID: 25543476 [TBL] [Abstract][Full Text] [Related]
40. PARP-1 expression in CD34+ leukemic cells in childhood acute lymphoblastic leukemia: relation to response to initial therapy and other prognostic factors. Kruk A; Ociepa T; Urasiński T; Grabarek J; Urasińska E Pol J Pathol; 2015 Sep; 66(3):239-45. PubMed ID: 26619102 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]